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INTRODUCTION
A recent survey of the effects of various physical
and chemical parameters on yolk protein in-
corporation by isolated Xenopus oocytes indicates
that the Vinca alkaloid vinblastine sulfate (VLB) is
among the more effective inhibitors of this process
(27). The Vinca alkaloids have received consider-
able attention because of their ability to disrupt
the integrity of microtubules (1, 2, 21)   therefore,
they appear to be useful tools for examining the
functions of microtubules in a variety of cells.
Furthermore, they facilitate the isolation and puri-
fication of microtubular proteins for biochemical
studies (4, 8, 17, 18) . These properties of VLB,
combined with its marked depressant effect on
protein uptake by isolated oocytes, led us to
examine VLB-treated oocytes for altered cyto-
logical characteristics. This communication de-
scribes alterations induced by VLB and discusses
their possible significance in terms of the relation-
ship of microtubules to the micropinocytotic
uptake of protein.
METHODS
Xenopus laeviswere maintained in the laboratory under
regulated conditions of temperature, light, and food
supply (26). Females used as oocyte donors were
injected with 1000 units of Human Chorionic
Gonadotropin (HCG) at least twice within 2 wk
before use. Oocytes (0.8-1 .1 mm) were isolated
under standard conditions in solution "0" and
subsequently incubated for 17 hr in protein-contain-
ing medium with or without 10-4 M VLB
("VELBAN", Eli Lilly   Co., Indianapolis, Ind.),
as described previously (27).
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After incubation, oocytes were fixed in 4  glutar-
aldehyde in 0.05 M phosphate buffer (pH 7.3),
washed overnight in the same buffer, and postfixed
in 1 01o osmium tetroxide in phosphate buffer . The
fixation procedures were carried out at 20  C. The
fixed oocytes were rapidly dehydrated in a graded
series of alcohols to propylene oxide, infiltrated, and
embedded in Epon. Thin sections were made with a
Porter-Blum MT-2 Ultramicrotome equipped with a
diamond knife, placed on Formvar-coated, carbon-
stabilized grids, stained with uranyl acetate and
lead citrate, and examined with an Hitachi 11-E
electron microscope operated at 75 kv.
RESULTS
Control Oocytes
Oocytes dissected from their follicles and cul-
tured in medium without VLB (Fig. 1) appear
similar to those in vivo (compare with Fig . 1,
ref. 25) . Follicle cells, which cover the freshly
isolated oocytes, are frequently absent after the
17-hr incubation period   the vitelline envelope,
however, remains intact. The oocyte surface
(oolemma) is highly folded and possesses deep
crypts and many microvilli.
A typical feature of oocytes actively incorporat-
ing protein, whether under in vitro or in vivo
conditions, is the presence of many micropino-
cytotic pits and vesicles (pinosomes) . Pinosomes
move centripetally, fuse with each other, and
form primordial yolk platelets. The primordial
yolk platelets further enlarge by fusion with others
or with more pinosomes and eventually trans-
form into yolk platelets which possess crystalline
605FIGURE 1 Control oocyte. Note the elaborate contours of the surface, micropinocytotic pits on the cell
surface and vesicles (pinosomes) in the peripheral ooplasm are abundant . Primordial yolk platelets (PYP)
appear swollen. Yolk platelets (YP) appear confined to discrete areas of the ooplasm, and melanosomes
(M) lie in a band beneath the cortical granules (CG). Vitelline envelope (VE). X 9100.FIGURE 2 An electron micrograph taken near the
surface of a control oocyte . Note microtubules (MT)
and pinosomes (P). X 33,600.
main bodies (10, 11). The primordial yolk plate-
lets formed in all isolated oocytes (including
those incubated in the presence of VLB) appear
to be somewhat swollen . They contain dense
aggregates of incorporated material, surrounded
by optically empty spaces . Some microtubules
are present and are generally located near the
periphery of the oocyte (Fig . 2). Extensive linear
arrays of microtubules, however, are not present.
VLB-Treated Oocytes
The most striking alteration of the oocyte
after VLB treatment is the change in its topog-
raphy (Fig. 3). The deep crypts disappear, and
the oolemma becomes smooth between project-
ing microvilli . Further, the number of micro-
pinocytotic pits and pinosomes is dramatically
reduced. There are more primordial yolk plat-
lets in VLB-treated oocytes than in controls .
Many of them possess spherical or slitlike "holes"
(Fig. 4) and are randomly distributed throughout
the ooplasm. Only rarely in control oocytes are
similar yolk platelet alterations observed . Many
of the smaller yolk platelets are also malformed
and possess holes and are often very irregular in
outline. Some contain uncrystallized condensa-
tions, presumably derived from fusion with pri-
mordial yolk platelets (Fig . 5) .
With the exception of the cortical granules,
which maintain their position in the periphery
of the oocyte, there is a general disorganization
of the ooplasm. That is, mitochondria, small yolk
platelets, and melanosomes which are normally
segregated from each other become intermingled .
Large crystals presumably composed of micro-
tubular proteins are present in VLB-treated
oocytes. The structure of these crystals is similar
to that described by others for microtubular
protein crystals induced by VLB in other cells
(3). Often, melanosomes and cisternae of the endo-
plasmic reticulum are closely apposed to the cir-
cumference of the crystals, an observation which
reflects the general disorganization of the ooplasm.
DISCUSSION
Microtubules participate in many cellular proc-
esses, ranging from development and maintenance
of cell shape (23, 24) and regulation of cell move-
ments and cytoplasmic particles (5, 6, 7, 12) to
involvement in secretory processes (14, 15, 20)
and mitosis (9, 13, 16, 19). Vinblastine, along
with other mitosis-arresting drugs such as vin-
cristine, colchicine, and colcemid, has the specific
effect of destroying or depolymerizing micro-
tubules and, as a result, affecting all of the
above-mentioned cellular processes. From the
cytological observations reported here, and in view
of the depression of protein uptake by oocytes in
the presence of VLB, it seems likely that micro-
tubules play an important role in the normal
processes of yolk acquisition and sequestration .
Because of their location and orientation near the
periphery of the oocyte, two possible roles are
hypothesized : (a) a structural role in maintain-
ing the elaborately contoured and micropinocyto-
tically active cell surface and (b) a role in directing
the centripetal movement and subsequent fusion
of pinosomes and primordial yolk platelets .
The observation that the number of micro-
pinocytotic pits and pinosomes is reduced in
VLB-treated oocytes undoubtedly accounts for
the lack of protein uptake . Of greater interest,
however, is the relationship of this process to the
known effects of VLB in destroying microtubule
integrity. Since the oocyte surface is altered by
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607FIGURE 3 The elaborate contours of the oocyte surface are lost from VLB-treated oocyte . Although the
cortical granules (CG) remain aligned beneath the oolemma, the primordial yolk platelets (PYP) and
melanosomes (M) now appear randomly distributed. Microtubule-protein crystals (MC) are present and
the endoplasmic reticulum (ER) appears swollen . Vitelline envelope (VE) . X 15,600.VLB, one possible interpretation is that micro-
tubules are necessary for maintaining the elaborate
surface in a configuration which promotes micro-
pinocytosis. Similar alterations of the cell surface,
accompanied by a reduction of micropinocytotic
activity caused by VLB and colchicine, have been
reported by others, with the suggestion that
microtubules acting as a cytoskeleton oppose the
deformation of the cell surface (5, 6) .
The second role hypothesized above for micro-
tubules in Xenopus oocytes is that they establish
boundaries within the ooplasm and aid in direct-
ing centripetal translocations of pinosomes and
primordial yolk platelets, thus facilitating the more
rapid fusion of these components by keeping them
in proximity to each other . The observation of a
general disorganization of the ooplasm and an
abundance of primordial yolk platelets in VLB-
treated oocytes supports this view . In other
words, in the absence of microtubules, pinosomes
and primordial yolk platelets are randomly dis-
tributed by cytoplasmic flow and as a conse-
quence are not spatially confined . Thus, although
micropinocytosis and the distribution of cyto-
plasmic components per se may not depend en-
tirely on the presence of microtubules, both
phenomena may be enhanced or promoted when
microtubules are present.
Although large numbers of microtubules are
not found in the normal oocyte, it would appear,
simply from the size and number of microtubular
crystals induced by VLB, that there is more
microtubular protein present than can be ac-
counted for by the number of microtubules ob-
served. It may be that relatively large quantities
of these proteins are synthesized by the oocyte and
simply stored in a depolymerized state until
needed for the construction of microtubules
during meiosis, cleavage, and subsequent em-
bryogenesis . It has been demonstrated that large
amounts of colchicine-binding protein are present
in the mature oocytes of Rana pipiens (22) .
The relationship of the malformation of primor-
FIGURE 4 Primordial yolk platelet from a VLB-treated
oocyte. Note the large "holes" which are characteristic
after VLB treatment. X 29,700.
FIGURE 5 Yolk platelets from a VLB-treated oocyte .
Much of the crystalline pattern has been destroyed,
their outlines are irregular, and they are now charac-
terized by slitlike holes which appear to outline the
main bodies. X 11,400.
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609dial yolk platelets and some smaller yolk platelets
to microtubules and/or the effects of VLB is un-
clear. It has been suggested that VLB, by virtue
of its high charge, alters the molecular arrange-
ment of microtubule proteins . It is possible that
it has similar effects on the integrity of yolk crystals,
and one may speculate that this highly charged
molecule acts either by interfering with the normal
crystallization of the primordial yolk platelets
or by "melting" yolk crystals that have already
formed.
Despite the interpretations offered in this re-
port, the possibility that VLB acts (a) directly on
the oolemma to alter its ability to incorporate by
micropinocytosis, (b) by binding with yolk pro-
teins to alter their incorporation and sequestration
by the oocyte, or (c) by precipitating other struc-
tural proteins (28) must be considered . However,
in light of the demonstrated effects of VLB on
microtubules and its apparent ineffectiveness in
changing other normal metabolic processes, such
as protein synthesis, the interpretations enum-
erated above seem most reasonable at this time .
In order to examine these alternatives, further
studies of the effects of other microtubule-altering
agents, such as colchicine, D20, and reduced
temperature, on the uptake of protein and on the
structure of the oocyte are in progress .
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